The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines
Abstract
The determination of an optimal treatment plan for an individual patient with rectal cancer is a complex process. In addition to decisions relating to the intent of rectal cancer surgery (ie, curative or palliative), consideration must also be given to the likely functional results of treatment, including the probability of maintaining or restoring normal bowel function/anal continence and preserving genitourinary functions. Particularly for patients with distal rectal cancer, finding a balance between curative-intent therapy while having minimal impact on quality of life can be challenging. Furthermore, the risk of pelvic recurrence is higher in patients with rectal cancer compared with those with colon cancer, and locally recurrent rectal cancer is associated with a poor prognosis. Careful patient selection and the use of sequenced multimodality therapy following a multidisciplinary approach is recommended. These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Rectal Cancer, including the addition of endoscopic submucosal dissection as an option for early-stage rectal cancer, updates to the total neoadjuvant therapy approach based on the results of recent clinical trials, and the addition of a “watch-and-wait” nonoperative management approach for clinical complete responders to neoadjuvant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bahadoer, R. R., Dijkstra, E. A., van Etten, B., Marijnen, C. A. M., Putter, H., Kranenbarg, E. M.-K., Roodvoets, A. G. H., Nagtegaal, I. D., Beets-Tan, R. G. H., Blomqvist, L. K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30555-6 · Cited by 1,693
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
Cercek, A., Lumish, M., Sinopoli, J., Weiss, J., Shia, J., Lamendola-Essel, M., El Dika, I. H., Segal, N., Shcherba, M., Sugarman, R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2201445 · Cited by 1,625
Self-citationConroy, T., Bosset, J.-F., Etienne, P.-L., Rio, E., François, É., Mesgouez-Nebout, N., Vendrely, V., Artignan, X., Bouché, O., Gargot, D., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00079-6 · Cited by 1,344
Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M., & Kryj, M. (2006) · British Journal of Surgery · doi:10.1002/bjs.5506 · Cited by 1,244
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer
Maas, M., Beets-Tan, R. G. H., Lambregts, D. M. J., Lammering, G., Nelemans, P. J., Engelen, S. M. E., van Dam, R. M., Jansen, R. L. H., Sosef, M., Leijtens, J. W. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.7176 · Cited by 1,117
Bailey, C. E., Hu, C.-Y., You, Y. N., Bednarski, B. K., Rodriguez-Bigas, M. A., Skibber, J. M., Cantor, S. B., & Chang, G. J. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.1756 · Cited by 1,077
Self-citationPeeters, K. C. M. J., van de Velde, C. J. H., Leer, J. W. H., Martijn, H., Junggeburt, J. M. C., Kranenbarg, E. K., Steup, W. H., Wiggers, T., Rutten, H. J., & Marijnen, C. A. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.779 · Cited by 943
Ngan, S. Y., Burmeister, B., Fisher, R. J., Solomon, M., Goldstein, D., Joseph, D., Ackland, S. P., Schache, D., McClure, B., McLachlan, S.-A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.9597 · Cited by 921
Renehan, A. G., Malcomson, L., Emsley, R., Gollins, S., Maw, A., Myint, A. S., Rooney, P. S., Susnerwala, S., Blower, A., Saunders, M. P., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00467-2 · Cited by 801
Garcia-Aguilar, J., Chow, O. S., Smith, D. D., Marcet, J. E., Cataldo, P. A., Varma, M. G., Kumar, A. S., Oommen, S., Coutsoftides, T., Hunt, S. R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00004-2 · Cited by 697
Self-citation
Metadata
- Authors
- Benson, A. B., Venook, A. P., Adam, M., Chang, G., Chen, Y.-J., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D., Garrido-Laguna, I., Grem, J. L., Haste, P., Hecht, J. R., Hoffe, S., Hunt, S., Hussan, H., Johung, K. L., Joseph, N., Kirilcuk, N., Krishnamurthi, S., Malla, M., Maratt, J. K., Messersmith, W. A., Meyerhardt, J., Miller, E. D., Mulcahy, M. F., Nurkin, S., Parikh, A., Patel, H., Pedersen, K., Saltz, L., Schneider, C., Shibata, D., Shogan, B., Skibber, J. M., Sofocleous, C. T., Tavakkoli, A., Willett, C. G., Wu, C., Jones, F., & Gurski, L.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2024-08
- Volume
- 22
- Issue
- 6
- Pages
- 366-375
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4401640776
- Cited by
- 282
- References
- 48
- FWCI
- 43.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines. https://app.cochat.ai/papers/10.6004/jnccn.2024.0041
- The paper
- Benson, A. B., Venook, A. P., Adam, M., Chang, G., Chen, Y.-J., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D., Garrido-Laguna, I., Grem, J. L., Haste, P., Hecht, J. R., Hoffe, S., Hunt, S., Hussan, H., Johung, K. L., Joseph, N., Kirilcuk, N., . . . Gurski, L. (2024). NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2024.0041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
